Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics
- PMID: 8095021
- DOI: 10.1016/0014-2999(93)90557-x
Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics
Abstract
The effects of three atypical neuroleptic compounds, clozapine, sulpiride, and (-)-3-(3-hydroxyphenyl)-N-n-propyl-piperidine ((-)-3-PPP) were compared to the effects of haloperidol and saline on excitatory amino acid levels in the rodent nucleus accumbens and corpus striatum after acute (1 day) and subchronic (28 days) treatment. Equivalent doses of each drug were determined by assessing their in vivo displacement of [3H]spiperone binding in the nucleus accumbens and corpus striatum. After acute treatment, all three atypical neuroleptics, but not haloperidol, produced a significant decrease in nucleus accumbens glutamate concentrations. Acute haloperidol treatment significantly elevated glutamate concentrations in the corpus striatum when compared to all three atypical drugs. After subchronic treatment, (-)-3-PPP significantly increased glutamate concentrations in the nucleus accumbens when compared to the effects of haloperidol and clozapine. There were no major between-group differences in glutamate levels after subchronic treatment in the corpus striatum. The effects of acute and subchronic neuroleptic administration on aspartate levels in the nucleus accumbens and corpus striatum were highly variable. These findings indicate that atypical and typical neuroleptics may alter subcortical excitatory amino acid levels in a site-specific manner.
Similar articles
-
Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics.Psychopharmacology (Berl). 1993;110(1-2):145-51. doi: 10.1007/BF02246964. Psychopharmacology (Berl). 1993. PMID: 7870875
-
Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11462-4. doi: 10.1073/pnas.95.19.11462. Proc Natl Acad Sci U S A. 1998. PMID: 9736759 Free PMC article.
-
Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.Brain Res. 1989 May 22;487(2):288-98. doi: 10.1016/0006-8993(89)90833-0. Brain Res. 1989. PMID: 2525063
-
Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.J Pharmacol Exp Ther. 1989 Feb;248(2):521-30. J Pharmacol Exp Ther. 1989. PMID: 2918468
-
Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects.Neurosci Biobehav Rev. 1994 Spring;18(1):111-20. doi: 10.1016/0149-7634(94)90041-8. Neurosci Biobehav Rev. 1994. PMID: 7909593 Review.
Cited by
-
Mechanisms of action of atypical antipsychotic drugs: a critical analysis.Psychopharmacology (Berl). 1996 Mar;124(1-2):2-34. doi: 10.1007/BF02245602. Psychopharmacology (Berl). 1996. PMID: 8935797 Review.
-
Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.Psychopharmacology (Berl). 2015 Jan;232(1):223-32. doi: 10.1007/s00213-014-3660-9. Epub 2014 Jul 4. Psychopharmacology (Berl). 2015. PMID: 24994553
-
Dopamine D(2) Antagonist-Induced Striatal Nur77 Expression Requires Activation of mGlu5 Receptors by Cortical Afferents.Front Pharmacol. 2012 Aug 14;3:153. doi: 10.3389/fphar.2012.00153. eCollection 2012. Front Pharmacol. 2012. PMID: 22912617 Free PMC article.
-
GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats.Psychopharmacology (Berl). 1994 Dec;116(4):517-22. doi: 10.1007/BF02247487. Psychopharmacology (Berl). 1994. PMID: 7701057
-
Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study.Neurochem Res. 2008 Sep;33(9):1869-80. doi: 10.1007/s11064-008-9660-6. Epub 2008 Mar 25. Neurochem Res. 2008. PMID: 18363098
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources